FDA shifts drug testing paradigm with plan to replace animal studies in monoclonal antibody development June 24, 2025July 9, 2025 Share More from the Blog Investigating key mechanisms of Parkinson’s with an αSyn fibril-induced brain-on-a-chip model Read More Boosting In Vitro Toxicology Testing with Organ-Chips Read More Advancing Precision Medicine with Patient-on-a-Chip Read More Browse All